Literature DB >> 15533375

Phosphatidylserine-dependent antiprothrombin antibodies are not useful markers for high-risk women with recurrent miscarriages.

Mayumi Sugiura-Ogasawara1, Tatsuya Atsumi, Yasuhiko Ozaki, Takao Koike, Kaoru Suzumori.   

Abstract

To determine the possible association between antiprothrombin antibodies and conventional antiphospholipid antibody (aPL) 1 (1.0%), 2 (2.0%) and 17 (17.0%) were found to be positive for phosphatidylserine-dependent antiprothrombin antibody (aPS/PT) IgG, beta2glycoprotein I-dependent anticardiolipin antibody, and lupus anticoagulant by activated partial thromboplastin time (LA), respectively, in 100 recurrent aborters. Because patients with aPS/PT were included in the 17 with LA, we should not add aPS/PT measurement to routine testing in addition to conventional aPL for patients with recurrent miscarriage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15533375     DOI: 10.1016/j.fertnstert.2004.06.034

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.

Authors:  N M Heikal; T D Jaskowski; E Malmberg; G Lakos; D W Branch; A E Tebo
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

2.  Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes.

Authors:  Polona Žigon; Katja Perdan Pirkmajer; Matija Tomšič; Tanja Kveder; Borut Božič; Snežna Sodin Šemrl; Saša Čučnik; Aleš Ambrožič
Journal:  J Immunol Res       Date:  2015-05-20       Impact factor: 4.818

3.  Detection of antiphosphatidylserine/prothrombin antibodies and their potential diagnostic value.

Authors:  Polona Žigon; Saša Čučnik; Aleš Ambrožič; Tanja Kveder; Snežna Sodin Šemrl; Blaž Rozman; Borut Božič
Journal:  Clin Dev Immunol       Date:  2013-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.